These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30777041)

  • 21. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The establishment of the objective diagnostic markers and personalized medical intervention in patients with major depressive disorder: rationale and protocol.
    Lv X; Si T; Wang G; Wang H; Liu Q; Hu C; Wang J; Su Y; Huang Y; Jiang H; Yu X
    BMC Psychiatry; 2016 Jul; 16():240. PubMed ID: 27422150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remote Monitoring Telemedicine (REMOTE) Platform for Patients With Anxiety Symptoms and Alcohol Use Disorder: Protocol for a Case-Control Study.
    Pastor N; Khalilian E; Caballeria E; Morrison D; Sanchez Luque U; Matrai S; Gual A; López-Pelayo H
    JMIR Res Protoc; 2020 Jun; 9(6):e16964. PubMed ID: 32579124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capturing Rest-Activity Profiles in Schizophrenia Using Wearable and Mobile Technologies: Development, Implementation, Feasibility, and Acceptability of a Remote Monitoring Platform.
    Meyer N; Kerz M; Folarin A; Joyce DW; Jackson R; Karr C; Dobson R; MacCabe J
    JMIR Mhealth Uhealth; 2018 Oct; 6(10):e188. PubMed ID: 30377146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Data Visualization Preferences in Remote Measurement Technology for Individuals Living With Depression, Epilepsy, and Multiple Sclerosis: Qualitative Study.
    Simblett S; Dawe-Lane E; Gilpin G; Morris D; White K; Erturk S; Devonshire J; Lees S; Zormpas S; Polhemus A; Temesi G; Cummins N; Hotopf M; Wykes T;
    J Med Internet Res; 2024 Oct; 26():e43954. PubMed ID: 39423366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remote monitoring technologies in Alzheimer's disease: design of the RADAR-AD study.
    Muurling M; de Boer C; Kozak R; Religa D; Koychev I; Verheij H; Nies VJM; Duyndam A; Sood M; Fröhlich H; Hannesdottir K; Erdemli G; Lucivero F; Lancaster C; Hinds C; Stravopoulos TG; Nikolopoulos S; Kompatsiaris I; Manyakov NV; Owens AP; Narayan VA; Aarsland D; Visser PJ;
    Alzheimers Res Ther; 2021 Apr; 13(1):89. PubMed ID: 33892789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reducing depressive symptomatology with a smartphone app: study protocol for a randomized, placebo-controlled trial.
    Giosan C; Cobeanu O; Mogoaşe C; Szentagotai A; Mureşan V; Boian R
    Trials; 2017 May; 18(1):215. PubMed ID: 28494802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation.
    Trivedi MH; Rush AJ; Ibrahim HM; Carmody TJ; Biggs MM; Suppes T; Crismon ML; Shores-Wilson K; Toprac MG; Dennehy EB; Witte B; Kashner TM
    Psychol Med; 2004 Jan; 34(1):73-82. PubMed ID: 14971628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Informing the Development of a Digital Health Platform Through Universal Points of Care: Qualitative Survey Study.
    Craven MP; Andrews JA; Lang AR; Simblett SK; Bruce S; Thorpe S; Wykes T; Morriss R; Hollis C;
    JMIR Form Res; 2020 Nov; 4(11):e22756. PubMed ID: 33242009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mobile sensing-based depression severity assessment in participants with heterogeneous mental health conditions.
    Lamichhane B; Moukaddam N; Sabharwal A
    Sci Rep; 2024 Aug; 14(1):18808. PubMed ID: 39138328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating a Remote Monitoring Program for Respiratory Diseases: Prospective Observational Study.
    Althobiani MA; Ranjan Y; Jacob J; Orini M; Dobson RJB; Porter JC; Hurst JR; Folarin AA
    JMIR Form Res; 2023 Nov; 7():e51507. PubMed ID: 37999935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(7):1-98. PubMed ID: 23074457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Google Health Digital Well-Being Study: Protocol for a Digital Device Use and Well-Being Study.
    McDuff D; Barakat A; Winbush A; Jiang A; Cordeiro F; Crowley R; Kahn LE; Hernandez J; Allen NB
    JMIR Res Protoc; 2024 May; 13():e49189. PubMed ID: 38743938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using a smartphone app to reduce cognitive vulnerability and mild depressive symptoms: Study protocol of an exploratory randomized controlled trial.
    Giosan C; Mogoaşe C; Cobeanu O; Szentágotai Tătar A; Mureşan V; Boian R
    Trials; 2016 Dec; 17(1):609. PubMed ID: 28031038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges in Using mHealth Data From Smartphones and Wearable Devices to Predict Depression Symptom Severity: Retrospective Analysis.
    Sun S; Folarin AA; Zhang Y; Cummins N; Garcia-Dias R; Stewart C; Ranjan Y; Rashid Z; Conde P; Laiou P; Sankesara H; Matcham F; Leightley D; White KM; Oetzmann C; Ivan A; Lamers F; Siddi S; Simblett S; Nica R; Rintala A; Mohr DC; Myin-Germeys I; Wykes T; Haro JM; Penninx BWJH; Vairavan S; Narayan VA; Annas P; Hotopf M; Dobson RJB;
    J Med Internet Res; 2023 Aug; 25():e45233. PubMed ID: 37578823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
    Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
    J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive reactivity versus dysfunctional cognitions and the prediction of relapse in recurrent major depressive disorder.
    Figueroa CA; Ruhé HG; Koeter MW; Spinhoven P; Van der Does W; Bockting CL; Schene AH
    J Clin Psychiatry; 2015 Oct; 76(10):e1306-12. PubMed ID: 26528654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using Smartphones and Wearable Devices to Monitor Behavioral Changes During COVID-19.
    Sun S; Folarin AA; Ranjan Y; Rashid Z; Conde P; Stewart C; Cummins N; Matcham F; Dalla Costa G; Simblett S; Leocani L; Lamers F; Sørensen PS; Buron M; Zabalza A; Guerrero Pérez AI; Penninx BW; Siddi S; Haro JM; Myin-Germeys I; Rintala A; Wykes T; Narayan VA; Comi G; Hotopf M; Dobson RJ;
    J Med Internet Res; 2020 Sep; 22(9):e19992. PubMed ID: 32877352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.